Michael Gerometta

Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study

E. Geoffrey Playford, Trent P. Munro, Stephen M. Mahler et al. · The Lancet Infectious Diseases · 2020 · 149 citations · Full text

Pharmacy, Immunology, Infectious Diseases +9

Single Photon Emission Computed Tomography of Pulmonary Emboli and Venous Thrombi Using Anti–D-Dimer

Timothy A. Morris, James J. Marsh, Peter G. Chiles et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 39 citations

Medicine, Nuclear Medicine, Radiology +17

Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate

Kim Wilson, Michael Gerometta, Dennis B. Rylatt et al. · Journal of Immunological Methods · 1991 · 33 citations

Life Sciences, Immunology, Infectious Diseases +16

Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial

David Macfarlane, Socrates Angelides, Paul R. Eisenberg et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 24 citations

Medicine, Nuclear Medicine, Radiology +14

Detection of Pulmonary Emboli With 99mTc-Labeled Anti–D-dimer (DI-80B3)Fab′ Fragments (ThromboView)

Timothy A. Morris, Michael Gerometta, Roger D. Yusen et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 24 citations

Medicine, Nuclear Medicine, Radiology +16